# ADAPY (Adaptimmune Therapeutics PLC) - SEC EDGAR Financial Statements

> Adaptimmune Therapeutics PLC reported $65.08M in revenue and a net loss of $169.8M for the trailing twelve months ended June 30, 2025 (down 89.3% year over year), with a 273.4% gross margin and a -252.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/ADAPY
- Markdown: https://convexityos.com/fundamentals/ADAPY.md
- SEC CIK: 0001621227
- Reporting currency: USD
- Latest filing period: June 30, 2025
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001621227&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $65.08M | -89.3% YoY |
| Operating Income | TTM | -$164.2M | -252.3% margin |
| Net Income | TTM | -$169.8M | -260.8% net margin |
| Diluted EPS | TTM | -$0.11 | Split-adjusted |
| Free Cash Flow | TTM | -$191.7M | -294.5% FCF margin |
| Cash & ST Investments | Jun 30, 2025 | $26.06M | Total debt: $48.68M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $178.0M | $60.28M | $27.15M | $6.15M | $3.96M | $1.12M | $59.51M | $37.83M | $14.20M | $9.87M |
| Cost of Revenue | $70K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $178.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $149.1M | $126.5M | $127.7M | $111.1M | $91.57M | $97.50M | $98.27M | $87.39M | $63.79M | $24.14M |
| Selling, General & Admin | $87.26M | $73.51M | $63.39M | -- | -- | -- | -- | -- | -- | -- |
| **Operating Income** | -$68.76M | -$139.7M | -$164.0M | -$162.2M | -$133.4M | -$139.8M | -$82.36M | -$80.66M | -$72.80M | -$24.64M |
| **EBITDA** | -$57.53M | -$129.9M | -$157.9M | -$155.7M | -$125.8M | -$131.8M | -$74.56M | -$75.24M | -$69.51M | -$23.91M |
| Interest Income | -- | -- | -- | -- | -- | $2.77M | $2.85M | $2.23M | $1.11M | $504K |
| Interest Expense | $3.35M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$67.24M | -$112.5M | -$163.0M | -$157.3M | -$129.9M | -$136.9M | -$95.02M | -$69.69M | -$70.69M | -$21.81M |
| Income Tax Expense | $3.58M | $1.34M | $2.50M | $791K | $162K | $242K | $497K | $451K | $892K | $244K |
| **Net Income** | -$70.81M | -$113.9M | -$165.5M | -$158.1M | -$130.1M | -$137.2M | -$95.51M | -$70.14M | -$71.58M | -$22.06M |
| Basic EPS | -$0.05 | -$0.09 | -$0.17 | -$0.17 | -$0.15 | -$0.22 | -$0.16 | -$0.13 | -$0.17 | -$0.17 |
| **Diluted EPS** | -$0.05 | -$0.09 | -$0.17 | -$0.17 | -$0.15 | -$0.22 | -$0.16 | -$0.13 | -$0.17 | -$0.17 |
| Basic Shares Outstanding | 1.51B | 1.21B | 967.2M | 934.8M | 854.8M | 629.8M | 584.3M | 527.6M | 424.7M | 214.7M |
| Diluted Shares Outstanding | 1.51B | 1.21B | 967.2M | 934.8M | 854.8M | 629.8M | 584.3M | 527.6M | 424.7M | 214.7M |

### Income Statement (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $13.68M | $7.29M | $3.22M | $40.90M | $128.2M | $5.68M | $231K | $7.32M |
| Cost of Revenue | $2.50M | $879K | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $11.18M | $6.41M | -- | -- | -- | -- | -- | -- |
| Research & Development | $22.98M | $28.86M | $39.10M | $34.30M | $40.45M | $35.21M | $33.21M | $37.79M |
| Selling, General & Admin | $18.48M | $23.28M | $27.17M | $21.28M | $19.08M | $19.73M | -- | $16.16M |
| **Operating Income** | -$30.29M | -$45.73M | -$73.52M | -$14.68M | $68.70M | -$49.26M | -$49.86M | -$46.63M |
| **EBITDA** | -$27.78M | -$43.27M | -$70.68M | -$11.86M | $71.44M | -$46.43M | -$46.98M | -$43.74M |
| Interest Expense | $962K | $1.88M | -- | $1.11M | $526K | -- | -- | -- |
| Income Before Tax | -$29.73M | -$47.01M | -$72.52M | -$16.79M | $70.05M | -$47.98M | -$48.57M | -$44.91M |
| Income Tax Expense | $612K | $575K | $1.69M | $831K | $526K | $526K | -$656K | $687K |
| **Net Income** | -$30.34M | -$47.58M | -$74.22M | -$17.62M | $69.52M | -$48.50M | -$47.92M | -$45.60M |
| Basic EPS | -$0.02 | -$0.03 | -- | -$0.01 | $0.05 | -$0.03 | -- | -$0.03 |
| **Diluted EPS** | -$0.02 | -$0.03 | -- | -$0.01 | $0.04 | -$0.03 | -- | -$0.03 |
| Basic Shares Outstanding | 1.58B | 1.54B | -- | 1.53B | 1.53B | 1.45B | -- | 1.36B |
| Diluted Shares Outstanding | 1.58B | 1.54B | -- | 1.53B | 1.56B | 1.45B | -- | 1.36B |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $91.14M | $144.0M | $108.0M | $149.9M | $56.88M | $50.41M | $68.38M | $84.04M | $158.8M | $194.3M |
| Short-Term Investments | $60.47M | $2.95M | $96.57M | $219.6M | $311.3M | $39.13M | $136.8M | $124.2M | -- | -- |
| **Cash & Short-Term Investments** | $151.6M | $146.9M | $204.6M | $369.6M | $368.2M | $89.54M | $205.1M | $208.3M | $158.8M | $194.3M |
| Accounts Receivable, Net | $1.45M | $821K | $7.43M | $752K | $139K | -- | $192K | $206K | $1.48M | $744K |
| Inventory | $7.32M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $3.17M | $2.41M | $1.93M | $2.08M | $444K | $1.81M | $439K | $382K | $976K | -- |
| **Total Current Assets** | $188.2M | $207.6M | $255.4M | $415.5M | $398.2M | $120.5M | $231.1M | $230.2M | $198.8M | $263.0M |
| Property, Plant & Equipment, Net | $31.31M | $50.95M | $53.52M | $30.49M | $27.78M | $31.07M | $36.12M | $40.68M | $27.90M | $13.22M |
| Intangible Assets | $3.88M | $330K | $442K | $1.00M | $1.73M | $2.20M | $1.47M | $1.34M | $1.27M | $305K |
| Other Non-Current Assets | $629K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $57.79M | $75.06M | $73.55M | $54.09M | $52.99M | $61.05M | $45.64M | $50.96M | $35.76M | $22.77M |
| **Total Assets** | $246.0M | $282.6M | $328.9M | $469.5M | $451.1M | $181.5M | $276.7M | $281.1M | $234.5M | $285.8M |
| Accounts Payable | $8.69M | $8.13M | $4.75M | $8.11M | $6.39M | $6.36M | $4.08M | $8.38M | $11.35M | $7.88M |
| Deferred Revenue (Current) | $12.30M | $28.97M | $23.52M | $22.20M | $2.83M | $2.13M | -- | $38.73M | $11.39M | $12.49M |
| Other Current Liabilities | $2.02M | $51K | $2.15M | $327K | $47K | $56K | $742K | $357K | $1.08M | $744K |
| **Total Current Liabilities** | $64.53M | $72.79M | $64.50M | $62.54M | $39.07M | $34.34M | $24.44M | $74.31M | $40.27M | $27.89M |
| Long-Term Debt | $50.24M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $95.81M | $149.1M | $160.9M | $177.2M | $49.26M | -- | -- | -- | $24.96M | $22.94M |
| Other Non-Current Liabilities | $4.27M | $1.40M | $1.30M | $673K | $644K | $598K | $5.41M | $3.85M | $3.14M | -- |
| **Total Non-Current Liabilities** | $169.6M | $170.3M | $182.5M | $201.0M | $70.84M | $23.56M | $5.41M | $3.85M | $28.10M | $22.94M |
| **Total Liabilities** | $234.1M | $243.1M | $247.0M | $263.6M | $109.9M | $57.91M | $29.85M | $78.16M | $68.37M | $50.83M |
| **Total Debt (incl. Leases)** | $74.21M | $25.23M | $23.08M | $25.47M | $23.71M | $25.46M | $26.00M | -- | -- | -- |
| Common Stock | $2.08M | $1.86M | $1.40M | $1.34M | $1.32M | $943K | $939K | $854K | $683K | $682K |
| Retained Earnings | -$1.09B | -$1.02B | -$909.3M | -$743.8M | -$585.8M | -$455.7M | -$318.5M | -$231.6M | -$161.5M | -$89.91M |
| Accumulated Other Comp. Income | -$1.90M | -$3.75M | -$875K | -$11.14M | -$10.05M | -$7.26M | -$9.76M | -$21.64M | -$14.25M | -$8.14M |
| **Total Stockholders' Equity** | $11.85M | $39.51M | $81.88M | $206.0M | $341.2M | $123.6M | $246.9M | $203.0M | $166.1M | $235.0M |
| Total Equity | $11.85M | $39.51M | $81.88M | $206.0M | $341.2M | $123.6M | $246.9M | $203.0M | $166.1M | $235.0M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.06M | $41.05M | $91.14M | $116.7M | $211.8M | $140.7M | $144.0M | $90.06M |
| Short-Term Investments | $0 | $18.51M | $60.47M | $69.35M | $2.98M | $2.98M | $2.95M | $71.67M |
| **Cash & Short-Term Investments** | $26.06M | $59.56M | $151.6M | $186.1M | $214.8M | $143.7M | $146.9M | $161.7M |
| Accounts Receivable, Net | $9.31M | $4.38M | $1.45M | $12.50M | $2.33M | $8.40M | $821K | $789K |
| Inventory | $11.41M | $11.76M | $7.32M | $1.87M | -- | -- | -- | -- |
| Other Current Assets | $3.52M | $3.35M | $3.17M | $3.38M | $3.29M | $2.84M | $2.41M | $1.68M |
| **Total Current Assets** | $78.11M | $103.0M | $188.2M | $244.2M | $253.8M | $186.9M | $207.6M | $219.4M |
| Property, Plant & Equipment, Net | $28.15M | $29.72M | $31.31M | $44.80M | $45.87M | $48.29M | $50.95M | $52.57M |
| Intangible Assets | $3.81M | $3.81M | $3.88M | $4.28M | $996K | $524K | $330K | $384K |
| Other Non-Current Assets | $94K | $377K | $629K | $968K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $52.52M | $55.07M | $57.79M | $73.22M | $67.93M | $71.11M | $75.06M | $77.27M |
| **Total Assets** | $130.6M | $158.1M | $246.0M | $317.4M | $321.7M | $258.0M | $282.6M | $296.6M |
| Accounts Payable | $9.42M | $5.70M | $8.69M | $9.07M | $7.51M | $6.59M | $8.13M | $13.92M |
| Deferred Revenue (Current) | $10.70M | $12.44M | $12.30M | $18.71M | $38.42M | $31.52M | $28.97M | $29.31M |
| Other Current Liabilities | $1.99M | $2.65M | $2.02M | $1.17M | $107K | $640K | $51K | $72K |
| **Total Current Liabilities** | $51.51M | $51.07M | $64.53M | $63.46M | $82.07M | $66.41M | $72.79M | $75.15M |
| Long-Term Debt | $25.68M | $25.41M | $50.24M | $49.87M | $24.95M | -- | -- | -- |
| Deferred Revenue (Non-Current) | $101.4M | $95.98M | $95.81M | $98.73M | $99.86M | $147.4M | $149.1M | $111.5M |
| Other Non-Current Liabilities | $4.49M | $4.37M | $4.27M | $4.94M | $1.44M | $1.42M | $1.40M | $1.36M |
| **Total Non-Current Liabilities** | $150.1M | $144.4M | $169.6M | $174.0M | $143.4M | $167.2M | $170.3M | $133.4M |
| **Total Liabilities** | $201.6M | $195.5M | $234.1M | $237.4M | $225.4M | $233.6M | $243.1M | $208.5M |
| **Total Debt (incl. Leases)** | $48.68M | $48.71M | $74.21M | $74.50M | $47.35M | $23.69M | $25.23M | $25.60M |
| Common Stock | $2.16M | $2.10M | $2.08M | $2.08M | $2.08M | $2.08M | $1.86M | $1.86M |
| Retained Earnings | -$1.17B | -$1.14B | -$1.09B | -$1.02B | -$1.00B | -$1.07B | -$1.02B | -$975.3M |
| Accumulated Other Comp. Income | -$10.61M | -$4.41M | -$1.90M | -$5.14M | -$3.41M | -$2.72M | -$3.75M | $102K |
| **Total Stockholders' Equity** | -$70.96M | -$37.43M | $11.85M | $79.99M | $96.27M | $24.38M | $39.51M | $88.13M |
| Total Equity | -$70.96M | -$37.43M | $11.85M | $79.99M | $96.27M | $24.38M | $39.51M | $88.13M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$70.81M | -$113.9M | -$165.5M | -$158.1M | -$130.1M | -$137.2M | -$95.51M | -$70.14M | -$71.58M | -$22.06M |
| Depreciation & Amortization | $11.22M | $9.84M | $6.08M | $6.57M | $7.59M | $8.01M | $7.81M | $5.42M | $3.29M | $735K |
| Stock-Based Compensation | $12.05M | $11.77M | $18.24M | $20.63M | $10.41M | $11.05M | $16.20M | $10.80M | $8.82M | $7.08M |
| Change in Inventory | -$7.36M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$73.21M | -$140.9M | -$141.8M | $10.73M | -$53.59M | -$112.5M | -$104.4M | -$54.31M | -$48.17M | -$29.67M |
| Capital Expenditure | -$886K | -$4.68M | -$29.50M | -$8.57M | -$2.34M | -$1.59M | -$3.91M | -$24.64M | -$11.51M | -$5.08M |
| **Free Cash Flow** | -$74.09M | -$145.6M | -$171.3M | $2.15M | -$55.93M | -$114.1M | -$108.3M | -$78.96M | -$59.67M | -$34.75M |
| Purchases of Investments | -$100.4M | -$75.95M | -$48.12M | -$139.8M | -$381.0M | -$27.28M | -$150.8M | -$153.3M | -- | -- |
| **Investing Cash Flow** | -$58.95M | $176.5M | $89.14M | $75.80M | -$278.9M | $94.94M | -$17.46M | -$126.1M | $17.75M | -$58.84M |
| Common Stock Issued | $29.17M | $624K | $12.82M | $2.53M | $334.4M | -- | $99.65M | $103.2M | -- | -- |
| **Financing Cash Flow** | $78.75M | $880K | $12.87M | $3.29M | $340.1M | $366K | $102.7M | $103.6M | $17K | $274.9M |
| **Net Change in Cash** | -$53.81M | $37.41M | -$42.06M | $90.18M | $6.58M | -$17.57M | -$15.82M | -$74.50M | -$35.98M | $177.9M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$30.34M | -$47.58M | -$74.22M | -$17.62M | $69.52M | -$48.50M | -$47.92M | -$45.60M |
| Depreciation & Amortization | $2.51M | $2.47M | $2.83M | $2.82M | $2.74M | $2.83M | $2.87M | $2.89M |
| Stock-Based Compensation | $1.32M | $669K | $2.84M | $3.06M | $3.06M | $3.10M | $3.08M | $3.18M |
| Change in Inventory | $385K | -$4.43M | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$34.78M | -$66.59M | -$34.20M | -$54.45M | $47.40M | -$31.95M | -$14.68M | -$45.16M |
| Capital Expenditure | -$75K | -$1.20M | -$219K | -$143K | -$422K | -$102K | -$827K | -$289K |
| **Free Cash Flow** | -$34.85M | -$67.80M | -$34.42M | -$54.59M | $46.98M | -$32.05M | -$15.50M | -$45.45M |
| Purchases of Investments | $0 | -$16.09M | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $18.49M | $41.15M | $8.17M | -$66.02M | -$743K | -$358K | $68.20M | $57.31M |
| Common Stock Issued | $1.65M | $122K | $1.0K | $0 | $10K | $29.16M | $1.0K | $435K |
| **Financing Cash Flow** | $1.65M | -$25.32M | $1.0K | $25.00M | $24.51M | $29.23M | $74K | $596K |
| **Net Change in Cash** | -$15.23M | -$50.20M | -$26.22M | -$95.25M | $71.15M | -$3.49M | $53.95M | $12.87M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 100.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -38.6% | -231.8% | -604.0% | -2638.6% | -3370.5% | -12457.2% | -138.4% | -213.2% | -512.7% | -249.6% |
| **Net Profit Margin** | -39.8% | -188.9% | -609.5% | -2571.0% | -3286.8% | -12225.0% | -160.5% | -185.4% | -504.1% | -223.5% |
| Return on Equity (ROE) | -597.6% | -288.2% | -202.1% | -76.8% | -38.1% | -110.9% | -38.7% | -34.6% | -43.1% | -8.5% |
| Return on Assets (ROA) | -28.8% | -40.3% | -50.3% | -33.7% | -28.8% | -75.6% | -34.5% | -24.9% | -30.5% | -7.3% |
| Current Ratio | 2.92x | 2.85x | 3.96x | 6.64x | 10.19x | 3.51x | 9.46x | 3.10x | 4.94x | 11.02x |
| Quick Ratio | 2.80x | 2.03x | 3.29x | 5.92x | 9.43x | 2.61x | 8.40x | 2.81x | 3.98x | 8.56x |
| Debt to Equity | 6.26x | 0.64x | 0.28x | 0.12x | 0.07x | 0.21x | 0.11x | -- | -- | -- |
| **Revenue Growth (YoY)** | +195.3% | +122.0% | +341.5% | +55.4% | +252.8% | -98.1% | +57.3% | +166.5% | -- | +1096.5% |
| Operating Cash Flow Growth (YoY) | -- | -- | -1421.4% | -- | -- | -- | -- | -- | -- | -180.5% |
| Free Cash Flow Growth (YoY) | -- | -- | -8047.3% | -- | -- | -- | -- | -- | -- | -198.0% |
| 5Y Revenue / Share Growth | +6501.5% | -50.9% | -60.9% | -80.3% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -252.3% | -36.3% | -38.6% | -25.8% | -54.5% | -1038.6% | -231.8% | -164.8% |
| **Net Profit Margin** | -260.8% | -38.9% | -39.8% | -25.4% | -51.3% | -890.1% | -188.9% | -133.9% |
| Return on Equity (ROE) | -- | -- | -597.6% | -55.7% | -75.3% | -670.4% | -288.2% | -108.0% |
| Return on Assets (ROA) | -129.9% | -44.2% | -28.8% | -14.0% | -22.5% | -63.3% | -40.3% | -32.1% |
| Current Ratio | 1.52x | 2.02x | 2.92x | 3.85x | 3.09x | 2.81x | 2.85x | 2.92x |
| Quick Ratio | 1.29x | 1.79x | 2.80x | 3.82x | 2.65x | 2.29x | 2.03x | 2.16x |
| Debt to Equity | -- | -- | 6.26x | 0.93x | 0.49x | 0.97x | 0.64x | 0.29x |
| **Revenue Growth (YoY)** | -89.3% | +28.3% | +1294.8% | +458.8% | +2399.6% | -88.1% | -97.9% | +4.5% |
| Operating Income Growth (YoY) | -144.1% | -- | -- | -- | -- | -3074.7% | -- | -- |
| **Net Income Growth (YoY)** | -143.6% | -- | -- | -- | -- | -4781.8% | -- | -- |
| EPS Growth (YoY) | -140.0% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -173.4% | -- | -- | -- | -- | -- | -818.7% | -- |
| Free Cash Flow Growth (YoY) | -174.2% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
